In the News

HepQuant DuO™ Estimates Risk for Clinical Outcome and Quantifies Changes in Risk

September 10, 2025

Dr. Greg Everson just shared groundbreaking insights at the Liver Forum in Paris! His presentation highlights how HepQuant DuO™ helps estimate clinical risk and track changes over time — a major step forward in liver disease management. [View his presentation here.]